When is a biotechnology invention really an invention?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
35 U.S.C. §101.
35 U.S.C. §102 and 103.
802 F.2d 1367, 1380 (Fed. Cir. 1986), cert, denied. 480 U.S. 947 (1987).
853 F.2d 894 (Fed. Cir. 1988).
991 F.2d 781, (Fed. Cir. 1993).
51 R.3d 1552 (Fed. Cir. 1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thomson, B., Gammon, S. Patenting Biotechnology: When the Means Justify the End. Nat Biotechnol 13, 1446–1448 (1995). https://doi.org/10.1038/nbt1295-1446
Issue Date:
DOI: https://doi.org/10.1038/nbt1295-1446